Ignite Creation Date:
2024-05-06 @ 7:00 PM
Last Modification Date:
2024-10-26 @ 2:58 PM
Study NCT ID:
NCT05861843
Status:
COMPLETED
Last Update Posted:
2023-11-28
First Post:
2023-04-24
Brief Title:
Craving Assessment in Patients With Alcohol Use Disorder Using Virtual Reality Exposure
Sponsor:
Charite University Berlin Germany
Organization:
Charite University Berlin Germany
Study Overview
Official Title:
Craving Assessment in Patients With Alcohol Use Disorder Using Virtual Reality Exposure
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CRAVE
Brief Summary:
Alcohol use disorder AUD is a burdensome clinical disorder with high relapse rates Virtual Reality VR-based therapeutic and diagnostic approaches have received increasing attention in the treatment of AUD but evidence on the induction of craving via VR scenarios is still needed Craving for alcohol is associated with psychological and physiological responses This single-arm clinical study will be conducted including n60 patients with AUD Using a head-mounted display HMD patients will be confronted with three different VR scenarios neutral vs two target situations while heart rate heart rate variability HRV pupillometry and electrodermal activity EDA will be measured continuously Subjective craving levels will be assessed pre-duringpost-exposure to each VR scenario
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None